MedPath

Comparison of PPI with H2RA plus egualen sodium combination therapy for the artificial ulcer after ESD

Not Applicable
Recruiting
Conditions
Early gastric cancer,Gastric adenoma
Registration Number
JPRN-UMIN000005429
Lead Sponsor
Kagawa university
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
60
Inclusion Criteria

Not provided

Exclusion Criteria

1)Patients who have anticoagulant or antiplatelet therapy 2)Patients who had total gastrectomy during the course observation. 3)Women during pregnancy or breast-feeding. 4)Patients who have sever liver, renal disease,

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath